NCT03886103View on ClinicalTrials.gov

Pharmacokinetics and Metabolism of (14C)-Labelled PXL770

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Healthy
Interventions
DRUG

14C labeled PXL770

Single administration

Trial Locations (1)

Unknown

Quotient, Nottingham

Sponsors

Lead Sponsor

Poxel SA
All Listed Sponsors
lead

Poxel SA

INDUSTRY

NCT03886103 - Pharmacokinetics and Metabolism of (14C)-Labelled PXL770 | Biotech Hunter | Biotech Hunter